BD Veritor System


Medical Tests


BD Veritor System

The system has a unique adaptive read technology - that helps reduce -positive results by examining the sample and compensating for many of the effects of non-specific binding to help deliver a more accurate read. Eliminates the need for visual-read and subjective interpretation by providing objective results on an easy-to-read digital display. Delivers results in minutes.

Product Features: 256082- BD Veritor System for Rapid Detection of SARS-CoV-2

Test type:  Chromatographic digital immunoassay intended for the direct and qualitative detection of SARS-CoV-2 nucleocapsid antigens that is used with the BD Veritor™ Plus Analyzer
Specimen type: Nasal (NS) swab specimens
Turnaround time: 15 minutes
CLIA complexity: Waived, Moderate, and High Complexity
FDA status: Emergency Use Authorization (EUA) Granted

Other Options: 

  • 256041- Influenza A+B Clinical Kit; Mod Complex
  • 256045- Influenza A+B POC Kit; CLIA Waived
  • 256042- RSV Clinical Kit; Mod Complex

Additional Information:

The BD Veritor System is a rapid detection system for influenza A and B, RSV, and SARS-CoV-2. It is available in a variety of options, including CLIA-waived options for flu A+B and RSV. The system comes with a quick start guide, product information leaflet, and fact sheet for individuals.